Disulfiram and Sinus tachycardia - a phase IV clinical study of FDA data
Sinus tachycardia is found among people who take Disulfiram, especially for people who are male, 50-59 old.
The phase IV clinical study analyzes which people take Disulfiram and have Sinus tachycardia. It is created by eHealthMe based on reports of 867 people who have side effects when taking Disulfiram from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
867 people reported to have side effects when taking Disulfiram.
Among them, 7 people (0.81%) have Sinus tachycardia.
What is Disulfiram?
Disulfiram has active ingredients of disulfiram. It is often used in alcoholism. eHealthMe is studying from 919 Disulfiram users for its effectiveness, alternative drugs and more.
What is Sinus tachycardia?
Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node) is found to be associated with 2,000 drugs and 1,276 conditions by eHealthMe.
Number of Disulfiram and Sinus tachycardia reports submitted per year:
Gender of people who have Sinus tachycardia when taking Disulfiram *:
- female: 50 %
- male: 50 %
Age of people who have Sinus tachycardia when taking Disulfiram *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 33.33 %
- 50-59: 50.0 %
- 60+: 16.67 %
Common drugs people take besides Disulfiram *:
- Indomethacin: 2 people, 28.57%
- Haloperidol: 2 people, 28.57%
- Atenolol: 2 people, 28.57%
- Nitroglycerin: 2 people, 28.57%
- Lisinopril: 2 people, 28.57%
- Fluoxetine: 2 people, 28.57%
- Citalopram Hydrobromide: 1 person, 14.29%
- Clonazepam: 1 person, 14.29%
- Escitalopram: 1 person, 14.29%
- Gabapentin: 1 person, 14.29%
Common side effects people have besides Sinus tachycardia *:
- Confusional State: 3 people, 42.86%
- Stress And Anxiety: 2 people, 28.57%
- Fatigue (feeling of tiredness): 2 people, 28.57%
- Hypotension (abnormally low blood pressure): 2 people, 28.57%
- Nausea (feeling of having an urge to vomit): 2 people, 28.57%
- Dizziness: 1 person, 14.29%
- Delirium (wild excitement): 1 person, 14.29%
- Depression: 1 person, 14.29%
- Diarrhea: 1 person, 14.29%
- Disturbance In Attention: 1 person, 14.29%
Common conditions people have *:
- Depression: 1 person, 14.29%
* Approximation only. Some reports may have incomplete information.
Do you take Disulfiram and have Sinus tachycardia?Check whether Sinus tachycardia is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Alternative drugs to, pros and cons of Disulfiram:
- Disulfiram (919 reports)
Sinus tachycardia treatments and more:
- Sinus tachycardia (18,041 reports)
COVID vaccines that are related to Sinus tachycardia:
- Sinus tachycardia in Moderna COVID Vaccine
- Sinus tachycardia in Pfizer BioNTech Covid Vaccine
- Sinus tachycardia in Johnson and Johnson Covid Vaccine
How severe was Sinus tachycardia and when was it recovered:
Expand to all the drugs that have ingredients of disulfiram:
Common drugs associated with Sinus tachycardia:
All the drugs that are associated with Sinus tachycardia:
- Sinus tachycardia (2,000 drugs)
Common conditions associated with Sinus tachycardia:
All the conditions that are associated with Sinus tachycardia:
- Sinus tachycardia (1,276 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on disulfiram (the active ingredients of Disulfiram) and Disulfiram (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Brain Stem Glioma and Lymphopenia - 3 seconds ago
- Valsartan and Edarbyclor drug interaction - 3 seconds ago
- Taxol and Idiopathic Thrombocytopenic Purpura - 5 seconds ago
- Cytarabine and Irritable Bowel Syndrome - 15 seconds ago
- Urobilinogen Urine Increased and johnson and johnson covid vaccine - 20 seconds ago